Evidence map›Paper›PMID 25699022›Full record

ArticleFrontiers in microbiology2015

Organic extracts from Indigofera suffruticosa leaves have antimicrobial and synergic actions with erythromycin against Staphylococcus aureus.

Ana Thereza Bezerra Dos Santos, Tiago Ferreira da Silva Araújo, Luis Cláudio Nascimento da Silva, Cleideana Bezerra da Silva, Antonio Fernando Morais de Oliveira, Janete Magali Araújo, Maria Tereza Dos Santos Correia, Vera Lúcia de Menezes Lima

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
7.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Colistin potentiation in multidrug-resistantFrontiers in microbiology · 2022
    Article
  8. Frontiers in veterinary science · 2022
    Article
  9. Article
  10. Advances in pharmacological sciences · 2018
    Review
  11. Review
  12. Article
  13. Combination of Erythromycin and Curcumin AlleviatesFrontiers in cellular and infection microbiology · 2017
    Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Ana Thereza Bezerra Dos SantosLaboratório de Química e Metabolismo de Lipídios e Lipoproteínas, Departamento de Bioquímica, Centro de Ciências Biológicas, Universidade Federal de Pernambuco Recife, Brazil.
Tiago Ferreira da Silva AraújoLaboratório de Química e Metabolismo de Lipídios e Lipoproteínas, Departamento de Bioquímica, Centro de Ciências Biológicas, Universidade Federal de Pernambuco Recife, Brazil.
Luis Cláudio Nascimento da SilvaLaboratório de Glicoproteínas, Departamento de Bioquímica, Centro de Ciências Biológicas, Universidade Federal de Pernambuco Recife, Brazil.
Cleideana Bezerra da SilvaLaboratório de Química e Metabolismo de Lipídios e Lipoproteínas, Departamento de Bioquímica, Centro de Ciências Biológicas, Universidade Federal de Pernambuco Recife, Brazil.
Antonio Fernando Morais de OliveiraLaboratório de Ecologia Aplicada e Fitoquímica, Departamento de Botânica, Centro de Ciências Biológicas, Universidade Federal de Pernambuco Recife, Brazil.
Janete Magali AraújoLaboratório de Genética de Microrganismos, Departamento de Antibióticos, Centro de Ciências Biológicas, Universidade Federal de Pernambuco Recife, Brazil.
Maria Tereza Dos Santos CorreiaLaboratório de Glicoproteínas, Departamento de Bioquímica, Centro de Ciências Biológicas, Universidade Federal de Pernambuco Recife, Brazil.
Vera Lúcia de Menezes LimaLaboratório de Química e Metabolismo de Lipídios e Lipoproteínas, Departamento de Bioquímica, Centro de Ciências Biológicas, Universidade Federal de Pernambuco Recife, Brazil.
Universidade Federal de Pernambuco · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A characteristic feature of Staphylococcus aureus is its ability to acquire resistance to antimicrobial agents. There is a need, therefore, for new approaches to combat this pathogen; for example, employing a combination of plant-derived products and antibiotics to overcome bacterial resistance. Indigofera suffruticosa is a plant popularly used to treat infections and has verified antimicrobial action. Here, we investigate the antimicrobial activity of different extracts from I. suffruticosa against S. aureus and their synergistic effects with erythromycin. Leaves of I. suffruticosa were extracted sequentially using diethyl ether, chloroform and acetone and the antimicrobial activity of each extract then tested against nine clinical isolates of S. aureus. Minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) were determined by microdilution tests, while the fractional inhibitory concentration (FIC) was assessed by checkerboard assay. All organic solvent extracts showed antimicrobial activity against S. aureus strains. The acetone extract was the most potent inhibitor of S. aureus (MIC and MBC of 0.78 and 3.12 mg/mL), followed by the chloroform extract (MIC and MBC of 3.12 and 6.25 mg/mL). Furthermore, acetone or chloroform extracts of I. suffruticosa enhanced the activity of erythromycin against S. aureus (FIC ≤ 0.5). We conclude that organic extracts from leaves of I. suffruticosa, alone or combined with erythromycin, are promising natural products for the development of new anti-S. aureus formulations.

Indexed as

antibacterial agentsmacrolide antibioticplant extractsS. aureus

Identifiers

PMID25699022
PMCPMC4313721
OpenAlexW2016211168

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.